PharmiWeb.com - Global Pharma News & Resources
12-Dec-2018

Global Wilson's Disease Drugs Market Report 2019-2023 Featuring Major Players - Bausch Health Companies, Mylan, Teva Pharmaceutical Industries, TSUMURA and Recordati - ResearchAndMarkets.com

The "Global Wilson's Disease Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The increase in strategic alliances to help market grow. Pharmaceutical companies are engaging in strategic alliances for the development of medications for the treatment of Wilson's disease. These alliances enhance the R&D activities for new drugs for the treatment of Wilson's disease. The analysts have predicted that the Wilson's disease drugs market will register a CAGR of almost 6% by 2023.

Market Overview

Increasing introduction of patient assistance programs

Patient assistance programs have been introduced to help patients who lack health insurance or prescription drug coverage to obtain the medications they need.

High cost of treatment

Despite the benefits of chelators, the price of these medicines poses a challenge to the market growth. The high cost of chelators will result in low patient adherence to chelator therapy. This, in turn, will hinder the growth of the global Wilson's disease drugs market.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Bausch Health Companies and Mylan the competitive environment is quite intense. Factors such as the rising increase in strategic alliances and increasing introduction of patient assistance programs, will provide considerable growth opportunities to Wilson's disease drugs manufactures. Bausch Health Companies, Mylan, Teva Pharmaceutical Industries, TSUMURA and Recordati are some of the major companies covered in this report.

With the presence of a considerable number of companies, this market appears to be fragmented. The strategic alliances enhance the R&D activities for new drugs for the treatment of Wilson's disease. Such alliances help companies develop new drugs for the treatment of Wilson's disease. It also helps in the faster development of therapeutic products.

Key Topics Covered:

01: Executive Summary

02: Scope Of The Report

03: Market Landscape

04: Market Sizing

05: Five Forces Analysis

06: Market Segmentation By Product

07: Customer Landscape

08: Geographic Landscape

09: Decision Framework

10: Drivers And Challenges

11: Market Trends

12: Vendor Landscape

13: Vendor Analysis

  • Bausch Health Companies
  • Mylan
  • Recordati
  • Teva Pharmaceutical Industries
  • Tsumura

For more information about this report visit https://www.researchandmarkets.com/research/84n7qw/global_wilsons?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181212005770/en/

Editor Details

Last Updated: 12-Dec-2018